Allergan Inc (AGN)

AGN (NYSE:Drugs)
$168.56
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | AGN Avg Daily Volume: 2,003,100
Last Update: 09/15/14 - 4:01 PM EDT
Volume: 0
YTD Performance: 51.75%
Open: $0.00
Previous Close: $168.56
52 Week Range: $87.88 - $174.49
Oustanding Shares: 297,183,809
Market Cap: 50,298,359,673
6-Month Chart
TheStreet Ratings Grade for AGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 7 5 6
Moderate Buy 0 0 0 0
Hold 6 5 7 7
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.23 2.08 2.38 2.29
Latest Dividend: 0.05
Latest Dividend Yield: 0.12%
Dividend Ex-Date: 08/13/14
Price Earnings Ratio: 38.82
Price Earnings Comparisons:
AGN Sector Avg. S&P 500
38.82 40.10 28.67
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
4.18% 89.88% 104.69%
GROWTH 12 Mo 3 Yr CAGR
Revenue 8.50 0.28 0.09
Net Income -10.30 258.69 5.26
EPS -9.80 0.00 0.00
Earnings for AGN:
EBITDA 2.07B
Revenue 6.30B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $1.47 $1.64 $5.79 $8.26
Number of Analysts 9 9 12 12
High Estimate $1.55 $1.69 $5.82 $8.37
Low Estimate $1.44 $1.53 $5.75 $7.74
Prior Year $1.23 $1.35 $4.77 $5.79
Growth Rate (Year over Year) 19.33% 21.23% 21.45% 42.55%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Sep 8, 2014 | 12:30 PM EDT

Sadly, these five themes have driven folks away from the market's remarkable five-year run.

By

Jim Cramer

 | Aug 12, 2014 | 11:42 AM EDT

TheStreet's Jim Cramer says Valeant's bid to acquire Allergan may have hit a 'high water mark.'

bullishAllergan upgraded at Leerink

Aug 8, 2014 | 7:40 AM EDT

AGN was upgraded from Market Perform to Outperform, Leerink Swann said. Risk/reward is compelling, following a significant pullback in the stock. $184 price target. 

By

Jim Cramer

 | Aug 7, 2014 | 11:47 AM EDT

Were Walgreen, Time Warner and Allergan too quick to dismiss the fast money?

By

Jim Cramer

 | Aug 6, 2014 | 6:06 AM EDT

We are now going to see a real test of the market's strength.

bullishAllergan upgraded at UBS

Jul 22, 2014 | 8:21 AM EDT

AGN was upgraded from Neutral to Buy, UBS said. $200 price target. The company plans to see more sales growth, while they consider a deal with Valeant.

bullishAllergan estimates, target raised at Leerink

Jul 22, 2014 | 7:21 AM EDT

Shares of AGN now seen reaching $184, according to Leerink Swann. Estimates also increased, as the company is aggressively cutting costs. Market Perform rating. 

By

Jim Cramer

 | Jul 21, 2014 | 3:53 PM EDT

The consensus of positives is just too cute.

By

Jim Cramer

 | Jul 17, 2014 | 1:10 PM EDT

There are amazing cross currents that make fundamental security analysis hard.

By

Jim Cramer

 | Jul 10, 2014 | 5:35 AM EDT

Cheap money and greed from the Allergan bidder's side are strong incentives.

If you are still long GS, it's time to really ratchet up those stops and it is at extensio...
Is the sell-off in the NASDAQ ( the RUT was down, too, back below its 50 and 200 day movi...
SCTY is trading $67.81, down 8.4% with IV30™ up 9.6%. Conclusion This is a stock and...
The stronger dollar and the removal of most of the ethanol premium, has landed sugar price...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.